Transcatheter tissue engineered heart valves

References

• Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005–1011 (2006).
   PubMed Web of Science ®Google Scholar
• Yacoub MH, Takkenberg JJ. Will heart valve tissue engineering change the world? Nat. Clin. Pract. Cardiovasc. Med. 2, 60–61 (2005).
   PubMedGoogle Scholar
• Otto CM. Timing of aortic valve surgery. Heart 84, 211–218 (2000).
   PubMed Web of Science ®Google Scholar
• Supino PG, Borer JS, Preibisz J, Bornstein A. The epidemiology of valvular heart disease: a growing public health problem. Heart Fail. Clin. 2, 379–393 (2006).
   PubMedGoogle Scholar
• Supino PG, Borer JS, Yin A, Dillingham E, McClymont W. The epidemiology of valvular heart diseases: the problem is growing. Adv. Cardiol. 41, 9–15 (2004).
   PubMed Web of Science ®Google Scholar
• Falk V, Schwammenthal EE, Kempfert J et al. New anatomically oriented transapical aortic valve implantation. Ann. Thorac. Surg. 87, 925–926 (2009).
   PubMed Web of Science ®Google Scholar
• Falk V, Walther T, Schwammenthal E et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur. Heart J. 32, 878–887 (2011).
   PubMed Web of Science ®Google Scholar
• Walther T, Dewey T, Borger MA et al. Transapical aortic valve implantation: step by step. Ann. Thorac. Surg. 87, 276–283 (2009).
   PubMed Web of Science ®Google Scholar
• Walther T, Mollmann H, van Linden A, Kempfert J. Transcatheter aortic valve implantation transapical: step by step. Semin. Thorac. Cardiovasc. Surg. 23, 55–61 (2011).
   PubMedGoogle Scholar
• Walther T, Simon P, Dewey T et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116, I240–I245 (2007).
   PubMed Web of Science ®Google Scholar
• Toggweiler S, Humphries KH, Lee M et al. 5-year outcome after transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 61, 413–419 (2013).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello BA, Chatterjee K et al. 2008 focused update incorporated into the acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J. Am. Coll. Cardiol. 52, e1–e142 (2008).
   Google Scholar
• Bonow RO, Carabello BA, Chatterjee K et al. Acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the society of cardiovascular anesthesiologists endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. J. Am. Coll. Cardiol. 48, e1–e148 (2006).
   Google Scholar
• Kvidal P, Bergstrom R, Horte LG, Stahle E. Observed and relative survival after aortic valve replacement. J. Am. Coll. Cardiol. 35, 747–756 (2000).
   PubMed Web of Science ®Google Scholar
• Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006–3008 (2002).
   PubMed Web of Science ®Google Scholar
• Vahanian A, Alfieri O, Al-Attar N et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the european association of cardio-thoracic surgery (eacts) and the european society of cardiology (esc), in collaboration with the european association of percutaneous cardiovascular interventions (eapci). Eur. Heart J. 29, 1463–1470 (2008).
   PubMed Web of Science ®Google Scholar
• Kraehenbuehl TP, Zammaretti P, Van der Vlies AJ et al. Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: systematic modulation of a synthetic cell-responsive peg-hydrogel. Biomaterials 29, 2757–2766 (2008).
   PubMed Web of Science ®Google Scholar
• Kiefer P, Gruenwald F, Kempfert J et al. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann. Thorac. Surg. 92, 155–160 (2011).
   PubMed Web of Science ®Google Scholar
• Zegdi R, Bruneval P, Blanchard D, Fabiani JN. Evidence of leaflet injury during percutaneous aortic valve deployment. Eur. J. Cardiothorac. Surg. 40, 257–259 (2011).
   PubMed Web of Science ®Google Scholar
• Weber B, Emmert MY, Schoenauer R, Brokopp C, Baumgartner L, Hoerstrup SP. Tissue engineering on matrix: future of autologous tissue replacement. Semin. Immunopathol. 33, 307–315 (2011).
   PubMed Web of Science ®Google Scholar
• Weber B, Emmert MY, Hoerstrup SP. Stem cells for heart valve regeneration. Swiss. Med. Wkly 142, w13622 (2012).
   PubMed Web of Science ®Google Scholar
• Langer R, Vacanti JP. Tissue engineering. Science 260, 920–926 (1993).
   PubMed Web of Science ®Google Scholar
• Yamanami M, Yahata Y, Uechi M et al. Development of a completely autologous valved conduit with the sinus of valsalva using in-body tissue architecture technology: a pilot study in pulmonary valve replacement in a beagle model. Circulation 122, S100–S106 (2010).
   Google Scholar
• Mol A, Smits AI, Bouten CV, Baaijens FP. Tissue engineering of heart valves: advances and current challenges. Expert Rev. Med. Devices 6, 259–275 (2009).
   PubMed Web of Science ®Google Scholar
• Brennan MP, Dardik A, Hibino N et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann. Surg. 248, 370–377 (2008).
   PubMed Web of Science ®Google Scholar
• Schmidt D, Dijkman PE, Driessen-Mol A et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J. Am. Coll. Cardiol. 56, 510–520 (2010).
   PubMed Web of Science ®Google Scholar
• Dijkman PE, Driessen-Mol A, de Heer LM et al. Transapical versus surgical implantation of autologous ovine tissue-engineered heart valves. J. Heart Valve Dis. 21, 670–678 (2012).
   PubMed Web of Science ®Google Scholar
• Boldt J, Lutter G, Pohanke J, Fischer G, Schoettler J, Cremer J, Metzner A. Percutaneous tissue-engineered pulmonary valved stent implantation: comparison of bone marrow-derived cd133+-cells and cells obtained from carotid artery. Tissue Eng. Part C Methods 19, 363–374 (2013).
   PubMedGoogle Scholar
• Lutter G, Metzner A, Jahnke T et al. Percutaneous tissue-engineered pulmonary valved stent implantation. Ann. Thorac. Surg. 89, 259–263 (2010).
   PubMedGoogle Scholar
• Metzner A, Stock UA, Iino K et al. Percutaneous pulmonary valve replacement: Autologous tissue-engineered valved stents. Cardiovasc. Res. 88, 453–461 (2010).
   PubMedGoogle Scholar
• Weber B, Scherman J, Emmert MY et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur. Heart J. 32(22), 2830–2840 (2011).
   PubMed Web of Science ®Google Scholar
• Dolgin E. Taking tissue engineering to heart. Nat. Med. 17, 1032–1035 (2011).
   PubMed Web of Science ®Google Scholar
• Roh JD, Sawh-Martinez R, Brennan MP et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc. Natl Acad. Sci. USA 107, 4669–4674 (2010).
   PubMed Web of Science ®Google Scholar
• Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 344, 532–533 (2001).
   PubMed Web of Science ®Google Scholar
• Shin’oka T, Matsumura G, Hibino N et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J. Thorac. Cardiovasc. Surg. 129, 1330–1338 (2005).
   PubMed Web of Science ®Google Scholar
• Weber B, Dijkman PE, Scherman J et al. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials 34, 7269–7280 (2013).
   PubMed Web of Science ®Google Scholar
• Driessen-Mo A, Emmert MY, Dijkmann PE et al. Transcatheter implantation of homologous “off-the-shelf” tissue engineered heart valves with self-repair capacity: long term functionality and rapid in vivo remodeling in sheep. J. Am. Coll. Cardiol. (2013) (In Press).
   Google Scholar
• Cale AR, Sang CT, Campanella C, Cameron EW. Hufnagel revisited: a descending thoracic aortic valve to treat prosthetic valve insufficiency. Ann. Thorac. Surg. 55, 1218–1221 (1993).
   PubMedGoogle Scholar
• Emmert MY, Weber B, Behr L et al. Transapical aortic implantation of autologous marrow stromal cell-based tissue-engineered heart valves: first experiences in the systemic circulation. JACC Cardiovasc. Interv. 4, 822–823 (2011).
   PubMed Web of Science ®Google Scholar
• Emmert MY, Weber B, Wolint P et al. Stem cell-based transcatheter aortic valve implantation: First experiences in a pre-clinical model. JACC Cardiovasc. Interv. 5, 874–883 (2012).
   PubMed Web of Science ®Google Scholar
• Emmert MY, Weber B, Behr L et al. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts. Eur. J. Cardiothorac. Surg. doi:10.1093/ejcts/ezt243 (2013) (Epub ahead of print).
   Google Scholar
• Schoen FJ. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 118, 1864–1880 (2008).
   PubMed Web of Science ®Google Scholar
• Schoen FJ. Heart valve tissue engineering: quo vadis? Curr. Opin. Biotechnol. 22(5), 698–705 (2011).
   PubMed Web of Science ®Google Scholar
• Dijkman PE, Driessen-Mol A, Frese L, Hoerstrup SP, Baaijens FP. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials 33, 4545–4554 (2012).
   PubMed Web of Science ®Google Scholar